Viral Strategy Uses Mitochondrial Remodeling to Evade Immune Response and Identify New Drug Opportunities
Scientists at The Wistar Institute have discovered how herpesviruses manipulate mitochondrial structure to evade immune responses, offering new drug development targets to treat virus-related diseases.
Researchers at The Wistar Institute have uncovered a novel mechanism employed by certain viruses to manipulate mitochondrial architecture, effectively silencing the host's immune response and facilitating viral replication. Published in Nature Microbiology, the study reveals how the viral protein vBcl-2, associated with Kaposi's sarcoma-linked herpesvirus (KSHV), exploits a host enzyme, NM23-H2, to induce mitochondrial fragmentation. This structural change prevents the formation of the MAVS signaling platform, a crucial component for antiviral defense mechanisms like Type I interferon production.
Traditionally known for its role in inhibiting cell death, vBcl-2 was found to have a more sophisticated function: remodeling mitochondria during a specific phase of the viral lifecycle. By activating NM23-H2, vBcl-2 promotes mitochondrial fission, disrupting immune signaling and enabling the virus to complete its late-stage assembly and exit the cell.
This process effectively destabilizes the immune response, preventing the activation of key antiviral proteins such as TRIM22 and MxB, which normally trap viral particles and inhibit their release. Furthermore, the team identified a small molecule, VBNI-1, capable of interfering with the vBcl-2 and NM23-H2 interaction. VBNI-1 successfully blocked mitochondrial fission and restored immune signaling pathways in laboratory models without harming uninfected cells, marking it as a promising candidate for targeted antiviral therapy.
The discovery highlights a potential new therapeutic target—the virus-induced mitochondrial remodeling process—and opens avenues for drug development against KSHV and other herpesviruses that may employ similar tactics. This interdisciplinary research underscores the importance of understanding virus-host interactions at the cellular level, paving the way for innovative treatments for virus-associated diseases.
For more details, see the full study here.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Gene Therapy Offers New Hope for Alagille Syndrome Patients
A novel gene therapy approach shows promise in treating Alagille syndrome, potentially reducing the need for liver transplants and reversing liver damage in affected patients.
Research Links Pathogen Adaptation to Autoimmune Risks in Han Chinese Population
A new study explores how HLA gene evolution in Han Chinese influences resistance to pathogens and risk of autoimmune diseases, highlighting the origins of immune-related conditions through evolutionary insights.
Early Eye Movements in Toddlers Predict Future Memory Judgment Abilities
Research shows that toddlers' eye movements during memory tasks can predict their ability to judge the accuracy of their memories one year later, highlighting the role of early visual exploration in developing self-awareness of memory.
Early Life Exposure to Dogs and Its Potential to Reduce Genetic Risk of Eczema
New research indicates that early exposure to dogs may protect children genetically predisposed to eczema by influencing immune-related genetic mechanisms, offering potential avenues for prevention.